|
|
Volumn 13, Issue 1, 2012, Pages 157-165
|
|
Rapid Synthesis of New DNMT Inhibitors Derivatives of Procainamide
a,b,c,f
a,c
a
a,c
b
d
a,c
d
b
e
b
d
b
b
|
|
Author keywords
Cancer; Conjugation; DNA methylation; Inhibitors; Rapid synthesis
|
|
Indexed keywords
3 [5 [[6 [[4 [[2 (DIETHYLAMINO)ETHYL]CARBAMOYL]PHENYL]AMINO]DODECYL]OXY] 1H INDOL 3 YL] 2 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)PROPANOIC ACID;
3 [5 [[6 [[4 [[2 (DIETHYLAMINO)ETHYL]CARBAMOYL]PHENYL]AMINO]HEXYLOXY] 1H INDOL 3 YL] 2 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)PROPANOIC ACID;
4 [(6 AMINODODECYL)AMINO]N[2 (DIETHYLAMINO)ETHYL]BENZAMIDE;
4 [(6 AMINOHEXYL)AMINO]N[2 (DIETHYLAMINO)ETHYL]BENZAMIDE;
4 [(6 AMINOTETRADECYL)AMINO]N[2 (DIETHYLAMINO)ETHYL]BENZAMIDE;
ANTINEOPLASTIC AGENT;
DNA METHYLTRANSFERASE 1;
DNA METHYLTRANSFERASE 3A;
DNA METHYLTRANSFERASE INHIBITOR;
N [2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)DECYL]AMINO]BENZAMIDE;
N [2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)DODECYL]AMINO]BENZAMIDE;
N [2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)OCTYL]AMINO]BENZAMIDE;
N [2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)TETRADECYL]AMINO]BENZAMIDE;
N PHTHALOYLTRYPTOPHAN;
N[2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)BUTYL]AMINO]BENZAMIDE;
N[2 (DIETHYLAMINO)ETHYL] 4 [[10 (1,3-DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL)HEXYL]AMINO]BENZAMIDE;
N[2 (DIETHYLAMINO)ETHYL] 4 [[6 [2 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL) 3 (1H INDOL 3 YL)PROPANAMIDO]HEXYL]AMINO]BENZAMIDE;
N[2 (DIETHYLAMINO)ETHYL] 4 [[6 [2 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL) 3 (1H INDOL 3 YL)PROPANAMIDO]TETRADECYL]AMINO]BENZAMIDE;
N[2 (DIETHYLAMINO)ETHYL] 4 [[6 [2 (1,3 DIOXO 2,3 DIHYDRO 1H ISOINDOL 2 YL] 3 (1H INDOL 3 YL)PROPANAMIDO]DODECYL]AMINO]BENZAMIDE;
PROCAINAMIDE;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CARBOXY TERMINAL SEQUENCE;
CELL STRAIN DU145;
CELL STRAIN HCT116;
COMPLEX FORMATION;
DRUG CYTOTOXICITY;
DRUG DETERMINATION;
DRUG MECHANISM;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
MALE;
PRIORITY JOURNAL;
PROTON NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DNA (CYTOSINE-5-)-METHYLTRANSFERASE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG SCREENING ASSAYS, ANTITUMOR;
ENZYME INHIBITORS;
HUMANS;
MICE;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PROCAINAMIDE;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
|
EID: 84155174668
PISSN: 14394227
EISSN: 14397633
Source Type: Journal
DOI: 10.1002/cbic.201100522 Document Type: Article |
|
Times cited : (58)
|
|
References (36)
|
